Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were mixed after the close on Thursday, as gains in the Financials, Healthcare and Consumer Goods sectors led shares higher while losses in the...
Investing.com – U.S. stocks were higher after the close on Thursday, as gains in the Basic Materials, Financials and Technology sectors led shares higher. At the close in NYSE,...
Investing.com – U.S. stocks were lower after the close on Monday, as losses in the Industrials, Technology and Financials sectors led shares lower. At the close in NYSE, the Dow...
Akers Biosciences Inc. (NASDAQ:AKER) recently announced favorable clinical results for its BreathScan OxiCheck disposable breath test. Following the news, shares surged 6.2% to...
Shares of Akers Biosciences Inc. (NASDAQ:AKER) increased almost 3% to close at $3.17 on Aug 11, after the company reported second-quarter 2016 results. We note that the company...
Shares of Akers Biosciences Inc. (NASDAQ:AKER) surged 15.8% to close at $3.22 following the completion of a clinical trial on the company’s Chlamydia rapid test, based on...
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MYMD-1 is a clinical-stage small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. MYMD-1 is being developed to treat age-related illnesses, such as frailty and sarcopenia. MYMD-1 works by regulating the release of numerous pro-inflammatory cytokines, such as TNF-a, interleukin 6 (IL-6) and interleukin 17 (IL-17). Supera-CBD is a synthetic analog of cannabidiol (CBD) being developed to treat various conditions, including epilepsy, pain and anxiety/depression, through its effects on the CB2 receptor, opioid receptors and monoamine oxidase enzyme (MAO) type B. Supera-CBD is also used in treating neuroinflammatory and neurodegenerative diseases.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.42 | 1.54 | 1.41 | -0.090 | -5.96% | 4.46M | NASDAQ | |||
| 102.78 | 114.05 | 102.48 | -7.72 | -6.99% | 30.72M | NYSE | |||
| 2,251.43 | 2,357.13 | 2,248.88 | -81.02 | -3.47% | 1.41M | NASDAQ | |||
| 0.71 | 0.82 | 0.45 | +0.327 | +85.33% | 461.78M | NASDAQ | |||
| 80.78 | 86.73 | 80.43 | -5.38 | -6.24% | 94.65M | NASDAQ | |||
| 106.48 | 110.31 | 106.38 | -2.03 | -1.87% | 846.44K | NYSE | |||
| 116.76 | 120.93 | 116.51 | -1.97 | -1.66% | 18.43M | NYSE | |||
| 24.18 | 24.43 | 23.85 | +0.29 | +1.21% | 68.98K | NYSE | |||
| 5.00 | 5.54 | 4.92 | -0.40 | -7.41% | 109.45K | NASDAQ | |||
| 13.94 | 14.25 | 13.77 | -0.15 | -1.06% | 613.65K | NASDAQ | |||
| 1.07 | 1.50 | 0.9278 | 0.0000 | 0.00% | 338.93M | NASDAQ | |||
| 24.77 | 24.93 | 24.49 | +0.63 | +2.61% | 10.45M | NYSE | |||
| 13.00 | 13.64 | 12.30 | +0.43 | +3.42% | 443.83K | NASDAQ | |||
| 32.80 | 34.10 | 32.76 | +0.10 | +0.31% | 615.62K | NYSE | |||
| 106.39 | 112.98 | 106.24 | -5.80 | -5.17% | 1.07M | NASDAQ |